Essity B 305.2 (+1.8 SEK) on 03-Dec-2024 17:31
Select region

Global Site

Austria Austria Belgium Belgium Canada Canada Denmark Denmark Finland Finland France France Germany Germany Italy Italy Mexico Mexico Netherlands Netherlands Norway Norway Poland Poland Spain Spain Sweden Sweden United Kingdom United Kingdom USA USA

Company

Essity at a Glance
Purpose and Vision Our Beliefs Our History
Business Areas
Health & Medical Consumer Goods Professional Hygiene Market and Trends
Breaking Barriers to Well-being
Stories Partnerships Insights Events
Strategy
Organization and Management
Board of Directors Executive Management Team
Corporate Governance
Articles of Association General Meeting Nomination Committee Auditors Board and Committee Work Remuneration to the Board of Directors Remuneration Policy Public Policies
Essity in the World
For Suppliers

Brands

Sustainability

Improving Well-Being for People and Societies
Hygiene and Health Diversity, Equity and Inclusion Business Ethics and Human Rights Occupational Health and Safety Product Safety and Transparency
Reducing Our Impact on the Planet
Forest and Fiber Emissions Plastics Waste Water
Sustainability Reporting, Governance and Data
Essity’s Sustainability Publications Sustainability Governance Ratings and Recognitions Certifications
Role in Society
Partnerships and Collaborations Essity in the Spotlight Ways of Working Trade Associations and Policy Organizations Public Policy Development Positions Advancing the Knowledge
Contact Us

Innovation

Products and Solutions
Digitalization
Essity Ventures
Latest Innovations

Careers

Job Opportunities
Work at Essity
Commitment to Our Employees Diversity, Equity and Inclusion Learning and Development Why Choose Essity? Barrier Breakers
Students and Graduates
Graduates Students Internships Apprenticeships
Life at Essity
Women in Technology Making HerStory Career Stories
Alumni Network
Connect with Us
Listen to us
Total Rewards

Investors

Invest in Essity
Targets and Outcomes
Essity Share
Ownership Dividend List of Analysts Share Buyback Program Share Conversion Share Capital Development Data per Share Trade Information Indexes
Financial Data
Financial Reports
Interim Reports Annual Reports Prospectus
Presentations and Webcasts
Capital Market Events
Capital Markets Day 2024 Innovation Webcast 2023 Business Area Web Presentations 2022 Capital Markets Day 2021 Investor Day 2019
Debt Financing
Debt Programs Credit Rating Funding Sources Key Debt Ratios
Acquisitions and Divestments
Risk and Risk Management
Investor Relations Calendar
Investor Relations Contacts
Subscribe

Media

Press Releases
News Features
Images & Video
Subscribe
Media Contact
Local Media Contacts
Essity in Social Media
Home
Company
Essity in the World
Australia & New Zealand

Prostate Cancer

Prostate Cancer is the most diagnosed cancer in Australia and New Zealand. It’s also the main reason men develop incontinence as prostate cancer treatment can damage the nerves and muscles that control the bladder.

Since 2019, TENA Men has been proud to be a major partner of the Prostate Cancer Foundation of Australia (PCFA) to support our common goal of championing men’s health and supporting men through incontinence.

TENA Men launched its Washable Underwear campaign ‘Wear it with Confidence’ in partnership with the Prostate Cancer Foundation of Australia (PCFA). The campaign features Ian and Ross, survivors of prostate cancer wearing the new underwear, beautifully photographed and filmed by Simon Harsent. The men share their stories of dealing with prostate cancer, their experience of facing incontinence, and the relief of having discreet, leak-absorbing underwear they can wear with confidence.

Mishael Raban, Marketing Manager for TENA, commented “By raising awareness and education we can break down the stigma of one of the biggest health taboos in today’s society. Whether it’s a small leak or a heavier flow, bladder leakage shouldn’t stop you from getting on with life.”

Anne Savage, CEO of Prostate Cancer Foundation of Australia, said the underwear would transform men’s experience of continence issues. “With more than 240,000 Australian men alive today after a diagnosis of prostate cancer, we know many will welcome the arrival of a product that safeguards their self-esteem and their social strength. We commend TENA for delivering a product that puts the person at the centre of the product, to solve a health challenge and significantly improve quality of life.”

TENA Men works with prostate cancer support groups and nurses to provide educational pamphlets and samples to help men see that there are many discreet options available to help them continue to live with confidence. We also provide their members with exclusive promotions and discounts to our online shop to help with the burden of buying incontinence products.